Comparative study on safety of linezolid and vancomycin in the treatment of infants and neonates for Gram-positive bacterial infections
Authors:
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 24 (9) , 695-701
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Labour and Welfare
This publication has 24 references indexed in Scilit:
- Linezolid versus vancomycin in the treatment of known or suspected resistant Gram-positive infections in neonatesThe Pediatric Infectious Disease Journal, 2003
- Linezolid versus vancomycin for treatment of resistant Gram-positive infections in childrenThe Pediatric Infectious Disease Journal, 2003
- Linezolid versus cefadroxil in the treatment of skin and skin structure infections in childrenThe Pediatric Infectious Disease Journal, 2003
- LinezolidPediatric Drugs, 2003
- Hematologic Effects of Linezolid: Summary of Clinical ExperienceAntimicrobial Agents and Chemotherapy, 2002
- Linezolid versus Vancomycin for the Treatment of Methicillin‐ResistantStaphylococcus aureusInfectionsClinical Infectious Diseases, 2002
- Prevalence of nosocomial infections in neonatal intensive care unit patients: Results from the first national point-prevalence surveyThe Journal of Pediatrics, 2001
- Linezolid for the treatment of community- acquired pneumonia in hospitalized childrenThe Pediatric Infectious Disease Journal, 2001
- Single dose pharmacokinetics of linezolid in infants and childrenThe Pediatric Infectious Disease Journal, 2000
- Nosocomial Infections in Pediatric Intensive Care Units in the United StatesPediatrics, 1999